As a result of yesterday's trading, European stock indices rose amid growth in the US and Asia-Pacific stock markets.
The composite index of the largest enterprises in the region Stoxx Europe 600 climbed 0.65% to 391.9 points.
The British FTSE 100 indicator rose 1.89%, the German DAX - 0.69%, the French CAC 40 - 1.14%. Italian FTSE and Spanish IBEX 35 added 0.18% and 0.79%, respectively.
Bayer AG shares gained 0.8%. The German chemical and pharmaceutical concern announced that it will raise about $ 1.65 billion by selling shares of Elanco Animal Health Inc., which the German company received as part of the deal to sell the American veterinary drug business..
Credit Suisse Group (SIX: CSGN) AG rose 1.4%. The Swiss bank may pay approximately $ 680 million to settle a dispute with MBIA Inc., a financial services firm, over residential mortgage-backed securities (RMBS). In addition, the Board of Directors of Credit Suisse has nominated Antonio Orta-Osorio, Chief Executive Officer of Lloyds Banking Group (LON: LLOY), as Chairman.
The market value of EDP-Energias de Portugal decreased by 1.3%. The Portuguese energy company announced that its head, Migal Stilvel de Andrade, at the request of shareholders, will propose new candidates for the EDP board. The company intends to hold a general meeting of shareholders in January 2021 to elect new board members.
UniCredit (MI: CRDI) SpA fell 8% after it became known that the chief executive officer of the Italian bank Jean-Pierre Mustier will leave his post in April 2021 due to differences in views on the future strategy of the bank with the board of directors.
Global stock markets continue to be supported by news about the coronavirus vaccine. The American company Moderna (NASDAQ: MRNA) announced that it has sent a request to the US Food and Drug Administration (FDA) for an emergency use of the COVID-19 vaccine. FDA plans to hold a meeting at which it will consider the application of the pharmaceutical company on December 17.
Moderna's vaccine is second in line for approval. US company Pfizer (NYSE: PFE) and Germany's BioNTech (NASDAQ: BNTX) on November 20 filed a request for emergency use in the US of their COVID-19 vaccine.
Investor optimism is also associated with data on industrial activity in China. China's Purchasing Managers' Index (PMI) by Caixin Media Co. and Markit, rose to a ten-year high in November as economic recovery continues to gain momentum after the COVID-19 crisis.
The number of unemployed in Germany in November fell by 39 thousand - to 2.817 million people, according to data from the Federal Agency for Employment of Germany. Unemployment fell to 6.1% from 6.2% in the previous month. This is the lowest level since April. Analysts on average predicted an increase in the number of unemployed by 8 thousand and an increase in unemployment to 6.3%, according to Trading Economics..
According to the final data of the research organization Markit Economics, the value of the PMI of the eurozone in the manufacturing industry in November was revised to 53.8 points from a preliminary 53.6 points. A month earlier, the indicator was 54.8 points.
The industrial PMI of France in November was also revised upward - to 49.6 points from the previously announced 49.1 points. The October value of the indicator was at the level of 51.3 points.
The index of activity in the manufacturing industry in Germany in November fell to 57.8 points from 58.2 points, and not to 57.9 points, as previously reported.
In the UK, the industrial PMI rose to 55.6 points from 53.7 points last month. Preliminary it was reported about the growth of the indicator to 55.2 points.
Consumer prices in the euro area in November 2020 fell by 0.3% on an annualized basis, according to preliminary data from the Statistical Office of the European Union. Analysts expected deflation to slow down to 0.2%, Trading Economics reports.
Комментарии
Отправить комментарий